Every one of these is a molecule

your body already makes.

We just make it measurable.

RESEARCH-GRADE PEPTIDES

Signals the body already knows how to read.

Six compounds. Documented mechanisms, honest evidence, and no claims we can’t cite.

SCROLL TO BEGIN
GHK-Cu 100mg vial, Quadra Biotech

GLY–HIS–LYS · Cu2+

GHK-Cu 100mg

MW 403.9 · TRIPEPTIDE–COPPER COMPLEX

Copper-binding tripeptide found naturally in plasma. Stimulates collagen and elastin production, with antioxidant and anti-inflammatory effects. Used mainly in skin repair, anti-ageing and hair-growth formulations.

HUMAN DATA · TOPICAL / COSMETIC

Learn more
BPC-157 10mg vial, Quadra Biotech

GEPPPGKPADDAGLV

BPC-157 10mg

MW 1419.5 · 15 RESIDUES · PENTADECAPEPTIDE

Synthetic peptide derived from a protein in gastric juice. Studied for accelerating repair of tendon, ligament, muscle and gut tissue by promoting new blood vessel formation. Evidence is animal-based; no completed human trials.

ANIMAL DATA ONLY · NO HUMAN TRIALS

Learn more
TB-500 10mg vial, Quadra Biotech

LKKTETQ

TB-500 10mg

MW 889.0 · THYMOSIN β4 ACTIVE FRAGMENT

Synthetic fragment of thymosin beta-4, a cell-migration protein. Associated with tissue repair, reduced inflammation and improved flexibility. Often paired with BPC-157 for recovery; again, animal and veterinary data only.

ANIMAL & VETERINARY DATA ONLY

Learn more
Retatrutide 10mg vial, Quadra Biotech

LY3437943

Retatrutide 10mg

MW 4731 · GLP-1 / GIP / GLUCAGON TRIAGONIST

Eli Lilly’s triple GLP-1/GIP/glucagon receptor agonist for obesity and type 2 diabetes. Suppresses appetite while also raising energy expenditure, producing around 24% average weight loss at 48 weeks in a Phase 2 trial. Still investigational, and not approved anywhere.

INVESTIGATIONAL · NOT APPROVED IN ANY JURISDICTION

Learn more
Tesamorelin 10mg vial, Quadra Biotech

trans-3-HEXENOYL-hGRF(1–44)-NH2

Tesamorelin 10mg

MW 5135.9 · 44 RESIDUES · GHRH ANALOGUE

Synthetic analogue of human growth-hormone-releasing hormone, stabilised against the enzyme that clears the native peptide within minutes. Approved in the United States for HIV-associated lipodystrophy — the only compound listed here that any regulator has licensed.

APPROVED MEDICINE · ONE INDICATION

Learn more
MOTS-c 40mg vial, Quadra Biotech

MRWQEMGYIFYPRKLR

MOTS-c 40mg

MW 2174.6 · 16 RESIDUES · MITOCHONDRIAL-DERIVED PEPTIDE

Sixteen-residue peptide encoded inside the mitochondrial 12S rRNA gene rather than the nuclear genome. Studied as a regulator of metabolic homeostasis through AMPK activation. Interventional evidence is rodent; the human work is observational.

ANIMAL DATA · EARLY HUMAN OBSERVATION

Learn more

What this site is, and what it isn’t.

Scope

Quadra Biotech supplies reference materials to laboratories, universities and contract research organisations. Everything listed here is sold for in vitro and non-human research use. Nothing on this site is offered for human or veterinary consumption, and nothing here is medical advice.

Evidence

Each compound carries its evidence status in the same viewport as its name: human, animal, veterinary, or investigational. Where the literature is thin, we say so. Where a mechanism is described, it is cited to a primary source you can read yourself.

Limits

We publish no dosing, no administration routes and no protocols. Storage and reconstitution conditions only. Five of the six compounds listed are unapproved by regulators in every jurisdiction, and the sixth is approved for one indication only; approval status is stated on every product.

Quadra Biotech makes no therapeutic claims. The descriptions on this site summarise published research and are not statements of efficacy or safety in humans. Checkout is disabled pending confirmation of jurisdictional supply restrictions.